Optimal Dose and #Safety of Intravenous #Favipiravir in Hospitalized Patients With #COVID19: A Dose-Escalating, Randomized Controlled Phase Ib Study, https://etidiohnew.blogspot.com/2026/03/optimal-dose-and-safety-of-intravenous.html
In a rare case, the brown eyes of a 6-month-old boy with COVID-19 turned blue after he was given the antiviral favipiravir.